Mild, Moderate, or Severe Alzheimer's Disease
1 clinical trials · Condition
◉ Watch Mild, Moderate, or Severe Alzheimer's Disease
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients (NCT06745583) | Elixiron Immunotherapeutics Inc. | 2024-12-16 |
Track Mild, Moderate, or Severe Alzheimer's Disease automatically
Every clearance here is in the API, with alerts when new ones post.